Ninerafaxstat well-tolerated and safe for nonobstructive hypertrophic cardiomyopathy

[Health - Medical Xpress - latest medical and]

The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with nonobstructive hypertrophic cardiomyopathy (HCM), according to results of a 12-week phase 2 trial presented at the American College of Cardiology's Annual Scientific Session.

Continue reading...